Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Gynecol Oncol. 2011 Oct 23;124(2):254–259. doi: 10.1016/j.ygyno.2011.10.019

Table 1b.

Selected Characteristics of 3 Hereditary Retinoblastoma Patients diagnosed with other pelvic malignancies

Patient Age at Ca dx (yrs) Age at Rb Dx (mos) Dose to Uterus (Gy) Vital Status Age at Death (yrs) Interval until Death (mos) Diagnosis
9 38 6 NR Dead 40 2 LMS retroperitoneum
10 44 17 0.17 Alive Uterine adenocarcinoma
11 49 19 No Rad Dead 49 0.03 Uterine Carcinoma, NOS

Ca, cancer; Dx, diagnosis; Rb retinoblastoma; LMS, leiomyosarcoma; NOS, not otherwise specified; NR, not recorded; No Rad, no radiation. Interval until death defined as months from ULMS diagnosis until death.